ZA200002263B - Process for the synthesis of nucleoside analogs. - Google Patents
Process for the synthesis of nucleoside analogs.Info
- Publication number
- ZA200002263B ZA200002263B ZA200002263A ZA200002263A ZA200002263B ZA 200002263 B ZA200002263 B ZA 200002263B ZA 200002263 A ZA200002263 A ZA 200002263A ZA 200002263 A ZA200002263 A ZA 200002263A ZA 200002263 B ZA200002263 B ZA 200002263B
- Authority
- ZA
- South Africa
- Prior art keywords
- synthesis
- nucleoside analogs
- nucleoside
- analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13365199P | 1999-05-11 | 1999-05-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200002263B true ZA200002263B (en) | 2001-12-24 |
Family
ID=22459680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200002263A ZA200002263B (en) | 1999-05-11 | 2000-05-09 | Process for the synthesis of nucleoside analogs. |
Country Status (22)
Country | Link |
---|---|
US (1) | US6271370B1 (de) |
EP (1) | EP1052264B1 (de) |
JP (1) | JP2001011092A (de) |
KR (1) | KR100403900B1 (de) |
CN (1) | CN1275575A (de) |
AR (1) | AR028991A1 (de) |
AT (1) | ATE291582T1 (de) |
AU (1) | AU3401100A (de) |
BR (1) | BR0002089A (de) |
CA (1) | CA2307951A1 (de) |
CZ (1) | CZ20001710A3 (de) |
DE (1) | DE60018833D1 (de) |
HU (1) | HUP0001843A3 (de) |
ID (1) | ID25992A (de) |
IL (1) | IL136027A0 (de) |
IN (1) | IN186850B (de) |
MX (1) | MXPA00004532A (de) |
PL (1) | PL340109A1 (de) |
RU (1) | RU2200738C2 (de) |
TR (1) | TR200001340A2 (de) |
YU (1) | YU25500A (de) |
ZA (1) | ZA200002263B (de) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200519106A (en) | 2003-05-02 | 2005-06-16 | Novartis Ag | Organic compounds |
GB0401334D0 (en) | 2004-01-21 | 2004-02-25 | Novartis Ag | Organic compounds |
GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
GB0424284D0 (en) | 2004-11-02 | 2004-12-01 | Novartis Ag | Organic compounds |
GB0426164D0 (en) | 2004-11-29 | 2004-12-29 | Novartis Ag | Organic compounds |
BRPI0611455A2 (pt) * | 2005-05-05 | 2010-09-08 | Ardea Biosciences Inc | diaril-purinas, azapurinas e deazapurinas como inibidores não nucleosìdicos da transcriptase reversa para tratamento de hiv |
GB0510390D0 (en) | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
CA2618089A1 (en) | 2005-08-08 | 2007-02-15 | Argenta Discovery Ltd. | Bicyclo[2.2.]hept-7-ylamine derivatives and their uses |
EP1957530A2 (de) | 2005-10-21 | 2008-08-20 | Novartis AG | Menschliche antikörper gegen il13 und therapeutische verwendungen |
GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
DE602007013441D1 (de) | 2006-09-29 | 2011-05-05 | Novartis Ag | Pyrazolopyrimidine als pi3k-lipidkinasehemmer |
CN101522682A (zh) | 2006-10-30 | 2009-09-02 | 诺瓦提斯公司 | 作为抗炎剂的杂环化合物 |
DK2327693T3 (da) | 2007-12-14 | 2012-08-13 | Pulmagen Therapeutics Asthma Ltd | Indoler og terapeutisk anvendelse deraf |
WO2009079412A2 (en) * | 2007-12-14 | 2009-06-25 | Ardea Biosciences Inc. | Reverse transcriptase inhibitors |
PL2231642T3 (pl) | 2008-01-11 | 2014-04-30 | Novartis Ag | Pirymidyny jako inhibitory kinazy |
WO2010088335A1 (en) | 2009-01-29 | 2010-08-05 | Novartis Ag | Substituted benzimidazoles for the treatment of astrocytomas |
CA2752693A1 (en) | 2009-02-17 | 2010-08-26 | Chiesi Farmaceutici S.P.A. | Triazolopyridine derivatives as p38 map kinase inhibitors |
GB0902648D0 (en) | 2009-02-17 | 2009-04-01 | Argenta Discovery Ltd | Pharmaceutical compounds and compositions |
WO2011005860A2 (en) * | 2009-07-07 | 2011-01-13 | Alnylam Pharmaceuticals, Inc. | 5' phosphate mimics |
US8389526B2 (en) | 2009-08-07 | 2013-03-05 | Novartis Ag | 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives |
EP2464649A1 (de) | 2009-08-12 | 2012-06-20 | Novartis AG | Heterocyclische hydrazonverbindungen und ihre verwendung zur behandlung von krebs und entzündung |
NZ598220A (en) | 2009-08-17 | 2014-02-28 | Intellikine Llc | Heterocyclic compounds and uses thereof |
MX2012002179A (es) | 2009-08-20 | 2012-03-16 | Novartis Ag | Compuestos heterociclicos de oxima. |
GB201009731D0 (en) | 2010-06-10 | 2010-07-21 | Pulmagen Therapeutics Inflamma | Kinase inhibitors |
WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
US8637516B2 (en) | 2010-09-09 | 2014-01-28 | Irm Llc | Compounds and compositions as TRK inhibitors |
JP2014505088A (ja) | 2011-02-10 | 2014-02-27 | ノバルティス アーゲー | C−METチロシンキナーゼ阻害剤としての[1,2,4]トリアゾロ[4,3−b]ピリダジン化合物 |
US9127000B2 (en) | 2011-02-23 | 2015-09-08 | Intellikine, LLC. | Heterocyclic compounds and uses thereof |
MA34969B1 (fr) | 2011-02-25 | 2014-03-01 | Irm Llc | Composes et compositions en tant qu inibiteurs de trk |
BR112014006223A8 (pt) | 2011-09-15 | 2018-01-09 | Novartis Ag | 3-(quinolin-6-iltio)-[1,2,4-triazol[4,3-a] piradinas 6-substituídas, seus usos, composições farmacêuticas, e combinação |
JP6130391B2 (ja) | 2011-11-23 | 2017-05-17 | インテリカイン, エルエルシー | Mtor阻害剤を使用する強化された治療レジメン |
BR112014013177A2 (pt) | 2011-12-09 | 2017-06-13 | Chiesi Farm Spa | composto, composição farmacêutica e uso de um composto |
WO2013083206A1 (en) | 2011-12-09 | 2013-06-13 | Chiesi Farmaceutici S.P.A. | Derivatives of 4-hydroxy-1,2,3,4-tetrahydronaphtalen-1-yl urea and their use in the treatment of, inter alia, diseases of the respiratory tract |
EA025268B1 (ru) | 2011-12-09 | 2016-12-30 | Кьези Фармачеутичи С. П. А. | Ингибиторы киназ |
MX371119B (es) | 2012-04-03 | 2020-01-17 | Novartis Ag | Productos de combinacion con los inhibidores de cinasa de tirosina y su uso. |
EP2867236B1 (de) | 2012-06-29 | 2017-06-14 | Pfizer Inc | Neue 4-(substituierte amino)-7h-pyrrolo[2,3-d]pyrimidine als lrrk2 hemmer |
JP2016512835A (ja) | 2013-03-15 | 2016-05-09 | インテリカイン, エルエルシー | キナーゼ阻害剤の組み合わせ及びそれらの使用 |
CN105377847A (zh) | 2013-06-06 | 2016-03-02 | 奇斯药制品公司 | 激酶抑制剂 |
EP3041841B1 (de) | 2013-09-05 | 2019-06-05 | F. Hoffmann-La Roche AG | Triazolopyridinverbindungen, zusammensetzungen und verfahren zur verwendung davon |
TW201605450A (zh) | 2013-12-03 | 2016-02-16 | 諾華公司 | Mdm2抑制劑與BRAF抑制劑之組合及其用途 |
US9695171B2 (en) | 2013-12-17 | 2017-07-04 | Pfizer Inc. | 3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors |
WO2016011658A1 (en) | 2014-07-25 | 2016-01-28 | Novartis Ag | Combination therapy |
JP6526789B2 (ja) | 2014-07-31 | 2019-06-05 | ノバルティス アーゲー | 組み合わせ療法 |
EP3265464A1 (de) | 2015-03-04 | 2018-01-10 | F. Hoffmann-La Roche AG | Triazolopyridinverbindungen und verfahren zur verwendung davon |
WO2017046675A1 (en) | 2015-09-14 | 2017-03-23 | Pfizer Inc. | Novel imidazo [4,5-c] quinoline and imidazo [4,5-c][1,5] naphthyridine derivatives as lrrk2 inhibitors |
TW201720828A (zh) | 2015-11-23 | 2017-06-16 | 赫孚孟拉羅股份公司 | 治療性化合物及組合物以及其使用方法 |
WO2017108737A1 (en) | 2015-12-23 | 2017-06-29 | Chiesi Farmaceutici S.P.A. | 1-(3-tert-butyl-phenyl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro- naphthalen-1-yl)-urea derivatives and their use as p38 mapk inhibitors |
MA44131A (fr) | 2015-12-23 | 2021-05-26 | Chiesi Farm Spa | Dérivés de 1-(3-tert-butyl-2h-pyrazol-5-yl or 5-tert-butyl-isoxaol-3-yl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalenyl) urée et leur utlisation en tant qu'inhibiteurs de p38 mapk |
AR107163A1 (es) | 2015-12-23 | 2018-03-28 | Chiesi Farm Spa | Inhibidores de quinasa |
JP7034942B2 (ja) | 2016-05-05 | 2022-03-14 | エフ.ホフマン-ラ ロシュ アーゲー | ピラゾール誘導体、その組成物及び治療的使用 |
RU2019109570A (ru) | 2016-09-06 | 2020-10-08 | Ф. Хоффманн-Ля Рош Аг | 8-(азетидин-1-ил)-[1,2,4]триазоло[1,5-а]пиридинилы, композиции и способы их применения |
EP3562809B1 (de) | 2016-12-29 | 2021-06-09 | F. Hoffmann-La Roche AG | Pyrazolopyrimidinverbindungen und verfahren zur verwendung davon |
JP2020510061A (ja) | 2017-03-14 | 2020-04-02 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | ピラゾロクロロフェニル化合物、組成物及びその使用方法 |
TW201900648A (zh) | 2017-05-22 | 2019-01-01 | 瑞士商赫孚孟拉羅股份公司 | 治療性化合物及組成物以及其使用方法 |
PE20200341A1 (es) | 2017-05-22 | 2020-02-14 | Hoffmann La Roche | Composiciones y compuestos terapeuticos y metodos para utilizarlos |
US10364245B2 (en) | 2017-06-07 | 2019-07-30 | Chiesi Farmaceutici S.P.A. | Kinase inhibitors |
JP7339263B2 (ja) | 2018-01-15 | 2023-09-05 | エフ. ホフマン-ラ ロシュ アーゲー | Jak阻害剤としてのピラゾロピリミジン化合物 |
EP3986899A1 (de) | 2019-06-18 | 2022-04-27 | F. Hoffmann-La Roche AG | Pyrazolopyrimidinaryletherinhibitoren von jak-kinasen und deren verwendung |
CN114026096A (zh) | 2019-06-18 | 2022-02-08 | 豪夫迈·罗氏有限公司 | 四唑取代的吡唑并嘧啶类jak激酶抑制剂及其用途 |
KR20220024405A (ko) | 2019-06-18 | 2022-03-03 | 에프. 호프만-라 로슈 아게 | Jak 키나제의 피라졸로피리미딘 설폰 억제제 및 그 사용 |
TW202140550A (zh) | 2020-01-29 | 2021-11-01 | 瑞士商諾華公司 | 使用抗tslp抗體治療炎性或阻塞性氣道疾病之方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61207400A (ja) * | 1985-03-11 | 1986-09-13 | Nippon Zoki Pharmaceut Co Ltd | ヌクレオシド化合物の製造方法 |
US4751292A (en) | 1985-07-02 | 1988-06-14 | The Plant Cell Research Institute, Inc. | Adamantyl purines |
US4859677A (en) | 1987-04-17 | 1989-08-22 | University Of Kansas | Nucleoside analogues having antiviral activity |
US5246931A (en) | 1988-10-25 | 1993-09-21 | Bristol-Myers Squibb Company | Carbocyclic nucleoside analogs |
US5688778A (en) | 1989-05-15 | 1997-11-18 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Nucleoside analogs |
GB8916480D0 (en) | 1989-07-19 | 1989-09-06 | Glaxo Group Ltd | Chemical process |
US5674998A (en) | 1989-09-15 | 1997-10-07 | Gensia Inc. | C-4' modified adenosine kinase inhibitors |
US5763596A (en) | 1989-09-15 | 1998-06-09 | Metabasis Therapeutics, Inc. | C-4' modified adenosine kinase inhibitors |
US5276151A (en) | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
US5470857A (en) | 1990-09-14 | 1995-11-28 | Marion Merrell Dow Inc. | Carbocyclic nucleoside analogs useful as immunosuppressants |
SE9003151D0 (sv) | 1990-10-02 | 1990-10-02 | Medivir Ab | Nucleoside derivatives |
ZA923640B (en) | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
GB9204015D0 (en) | 1992-02-25 | 1992-04-08 | Wellcome Found | Therapeutic nucleosides |
TW374087B (en) | 1993-05-25 | 1999-11-11 | Univ Yale | L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents |
WO1996004293A1 (fr) * | 1994-08-02 | 1996-02-15 | Banyu Pharmaceutical Co., Ltd. | Indolopyrrolocarbazoles antitumoraux |
US5659023A (en) | 1995-02-01 | 1997-08-19 | Gilead Sciences, Inc. | Nucleotide analogues |
WO1997027204A1 (en) | 1996-01-23 | 1997-07-31 | The Regents Of The University Of Michigan | Modified benzimidazole nucleosides as antiviral agents |
-
2000
- 2000-05-03 YU YU25500A patent/YU25500A/sh unknown
- 2000-05-08 US US09/566,468 patent/US6271370B1/en not_active Expired - Fee Related
- 2000-05-08 IL IL13602700A patent/IL136027A0/xx unknown
- 2000-05-08 IN IN421MU2000 patent/IN186850B/en unknown
- 2000-05-09 EP EP00303892A patent/EP1052264B1/de not_active Expired - Lifetime
- 2000-05-09 CA CA002307951A patent/CA2307951A1/en not_active Abandoned
- 2000-05-09 DE DE60018833T patent/DE60018833D1/de not_active Expired - Lifetime
- 2000-05-09 ZA ZA200002263A patent/ZA200002263B/xx unknown
- 2000-05-09 JP JP2000135874A patent/JP2001011092A/ja active Pending
- 2000-05-09 AR ARP000102222A patent/AR028991A1/es active IP Right Grant
- 2000-05-09 BR BR0002089-3A patent/BR0002089A/pt not_active IP Right Cessation
- 2000-05-09 AT AT00303892T patent/ATE291582T1/de not_active IP Right Cessation
- 2000-05-10 HU HU0001843A patent/HUP0001843A3/hu unknown
- 2000-05-10 CN CN00107145A patent/CN1275575A/zh active Pending
- 2000-05-10 KR KR10-2000-0024885A patent/KR100403900B1/ko not_active IP Right Cessation
- 2000-05-10 ID IDP20000389D patent/ID25992A/id unknown
- 2000-05-10 CZ CZ20001710A patent/CZ20001710A3/cs unknown
- 2000-05-10 RU RU2000111438/04A patent/RU2200738C2/ru not_active IP Right Cessation
- 2000-05-10 AU AU34011/00A patent/AU3401100A/en not_active Abandoned
- 2000-05-10 MX MXPA00004532A patent/MXPA00004532A/es unknown
- 2000-05-11 TR TR2000/01340A patent/TR200001340A2/xx unknown
- 2000-05-11 PL PL00340109A patent/PL340109A1/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0001843A2 (hu) | 2001-06-28 |
CZ20001710A3 (cs) | 2001-09-12 |
YU25500A (sh) | 2003-08-29 |
MXPA00004532A (es) | 2002-03-08 |
HUP0001843A3 (en) | 2001-09-28 |
EP1052264A3 (de) | 2001-06-13 |
RU2200738C2 (ru) | 2003-03-20 |
HU0001843D0 (en) | 2000-07-28 |
JP2001011092A (ja) | 2001-01-16 |
ID25992A (id) | 2000-11-16 |
DE60018833D1 (de) | 2005-04-28 |
KR20010069193A (ko) | 2001-07-23 |
TR200001340A2 (tr) | 2000-12-21 |
IL136027A0 (en) | 2001-05-20 |
US6271370B1 (en) | 2001-08-07 |
CA2307951A1 (en) | 2000-11-11 |
AU3401100A (en) | 2000-11-16 |
EP1052264B1 (de) | 2005-03-23 |
EP1052264A2 (de) | 2000-11-15 |
CN1275575A (zh) | 2000-12-06 |
AR028991A1 (es) | 2003-06-04 |
BR0002089A (pt) | 2001-01-02 |
PL340109A1 (en) | 2000-11-20 |
KR100403900B1 (ko) | 2003-11-01 |
ATE291582T1 (de) | 2005-04-15 |
IN186850B (de) | 2001-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200002263B (en) | Process for the synthesis of nucleoside analogs. | |
HK1039487A1 (en) | Process for the synthesis of azetidinones. | |
ZA992877B (en) | Process for the preparation of hyndrocarbons from synthesis gas. | |
IL135562A0 (en) | Process for the synthesis of 1,3-diols | |
IL138495A0 (en) | Process for the preparation of epoxides from olefins | |
EG23909A (en) | Vatamin d, analogs | |
GB9905422D0 (en) | Process for the production of olefins | |
IL162059A0 (en) | Process for the synthesis of -amino- chirally purealcohols | |
IL139023A0 (en) | Process for the preparation of 2,3,5-trimethyl-p- benzoquinone | |
ZA200108392B (en) | Process for the preparation of substituted pyrimidines. | |
AU7727700A (en) | Robust process for the synthesis of polyestercarbonates | |
HUP0203407A3 (en) | Process for the preparation of pyrazolopyridazine derivatives | |
GB2343892B (en) | Process for the preparation of d,l-menthol | |
MXPA03006606A (es) | Proceso para preparacion de analogos de indeno heterociclico. | |
EP1175432A4 (de) | Verfahren zur herstellung von oligomeren unter verwendung von phosphoramidit-zusammensetzungen | |
HUP0004631A3 (en) | Process for the production of avermectin compounds | |
EP1554298A4 (de) | Verfahren zur herstellung von 9-beta-anomeren nukleosidanaloga | |
MXPA03002926A (es) | Proceso para la sintesis de 2,2,6,6,-tetrametil-4--oxipiperidina. | |
ZA989338B (en) | Process for the synthesis of chloropurine intermediates. | |
IL138691A (en) | Process for the preparation of 3-acyl-indoles | |
HUP0202865A3 (en) | Process for the preparation of 2-cyanopyridines | |
MXPA01001471A (es) | Nuevo proceso para la sintesis de exoquelinas. | |
EP1186612A4 (de) | Verfahren zur herstellung von cytidin-derivaten | |
HUP0102089A3 (en) | Process for the preparation of nitroguanidine derivatives | |
PL376098A1 (en) | Process for the synthesis of 3,3a,6,6a-tetrahydro-2h-cyclopentan [b] furan-2-one |